As mentioned before, asprosin causes hyperinsulinemia and IR which in turn could affect oxidant-antioxidant balance and increase the expression of Insulin-like growth factor 1 (IGF-1) (12, 46) which promotes cancer development and metastasis (106). Here, IGF1 is linked to Hyperinsulinemia.